Kelun Pharmaceutical : The company’s innovative drug KL340399 injection (STING agonist) intratumoral injection for the treatment of advanced solid tumors has received a clinical trial notice.
Xinlitai: The "Left Atrial Appendage Occluder System" (LAMax LAAC) independently developed by its subsidiary Coyton has obtained registration approval from the National Medical Products Administration .
CSG A (000012.SZ): 2021: Plans to distribute 2 yuan for every 10 shares ex-rights and ex-dividend on June 24.
China Merchants Bank : Wang Liang’s qualifications as President of China Merchants Bank have been approved by China Banking and Insurance Regulatory Commission , and his term will take effect from the approval date of June 15, 2022.
Midea Group : The main raw materials for the company’s consumer appliances and core component products are various grades of copper, steel, and aluminum. The prices of these bulk raw materials have risen rapidly and significantly recently, which may objectively have a certain impact on the company’s operating performance.
CATL : On June 15, a large transaction occurred at a discount of 23.03 million yuan, with a transaction price of 464.46 yuan per share. Both buyers and sellers were institutions.
Zhongshan Public Utilities: Fosun Group , a shareholder holding more than 5% of the shares, plans to continue to reduce its shareholding by no more than 6%.
Yiling Pharmaceutical : Present the company's health products to all shareholders, including 1 Lianhua Qingyan Antibacterial Spray and 1 box of Lianhua Mask Explosive Beads.
Massive data : The controlling shareholder and actual controller received a notice of filing from the China Securities Regulatory Commission, suspected of illegal disclosure of information on changes in shareholdings and restricted period trading. According to relevant laws and regulations, the China Securities Regulatory Commission decided to prosecute the company’s controlling shareholder and actual controller. File a case.
Alloy Investment : The controlling shareholder Tonghai Investment plans to transfer all 20% of its shares to Guanghui Energy for a total transfer price of 750 million yuan.
Yabao Pharmaceutical: COVID-19 drug YBSW015 injection has obtained permission to conduct Phase I clinical trials in Australia.
Bailey Technology: Signed a general engineering contract worth 1.373 billion yuan, accounting for 131.83% of the company’s audited operating income in the most recent year.
Jinko Technology: Plans to transfer 44% equity of its joint-stock company Luquan New Energy.
Dongwang Times: Plans to sell 100% equity of Guangsha Culture to Dongyang Culture and Tourism for 65 million yuan.
Tofflon : Plans to sell 10% of Dazhong Small Loan shares for 22.615 million yuan.
Jiahe Intelligence: Net profit in the first half of the year is expected to increase by 60%-100% year-on-year. During the reporting period, the company strengthened the development of new products and emerging markets; continued to optimize the production layout, and actively built a three-in-one production base of "Dongguan-Vietnam-Jiangxi", resulting in a significant increase in product gross profit margin.
Runjian Co., Ltd.: Signed a new energy project cooperation agreement with a total investment of approximately 3.4 billion yuan.
Aolian Electronics: Signed a strategic cooperation agreement with Luobide to jointly produce 100,000 commercial intelligent robots in the next three years.
Guanghui Energy: Plans to invest 2 billion yuan to establish a new subsidiary, mainly engaged in the development and operation of Malang Coal Mine.
Tianshun Wind Energy : The holding subsidiary plans to sign a 481 million yuan project contract with Shenzhen Smart Energy.
